Keeping up to date: a current review of wearable cardioverter defibrillator use

References

• Epstein AE, Abraham WT, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62(21):2000–2007.
   Web of Science ®Google Scholar
• Feldman AM, Klein H, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27(1):4–9.
   Web of Science ®Google Scholar
• Schott R. Wearable defibrillator. J Cardiovasc Nurs. 2002;16(3):44–52.
   Google Scholar
• Piccini JP, Sr., Allen LA, et al. Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association. Circulation. 2016;133(17):1715–1727.
   Web of Science ®Google Scholar
• Reek S, Geller JC, Meltendorf U, et al. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol. 2003;26(10):2016–2022.
   Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation. 2018;138(13):e210–e271.
   PubMed Web of Science ®Google Scholar
• Bardy GH, Lee KL, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomstrom-Lundqvist C, et al. [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology]. G Ital di Cardiol. 2016;17:108–170.
   Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–408.
   PubMed Web of Science ®Google Scholar
• Chung MK, Szymkiewicz SJ, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56(3):194–203.
   Web of Science ®Google Scholar
• Olgin JE, Pletcher MJ, et al. Wearable cardioverter-defibrillator after myocardial infarction. N Engl J Med. 2018;379(13):1205–1215.
   Web of Science ®Google Scholar
• Steinbeck G, Andresen D, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361(15):1427–1436.
   PubMed Web of Science ®Google Scholar
• Hohnloser SH, Kuck KH, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481–2488.
   PubMed Web of Science ®Google Scholar
• Verdino RJ. The wearable cardioverter-defibrillator: lifesaving attire or “fashion faux pas?” J Am Coll Cardiol. 2010;56(3):204–205.
   Web of Science ®Google Scholar
• Sander GD, Owens DK, Hlatky MA. Potential cost-effectiveness of wearable cardioverter-defibrillator early post myocardial infarction. J Innov Cardiac Rhythm Manage. 2015;6:1929–1940.
   Google Scholar
• Kadish A, Dyer A, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–2158.
   PubMed Web of Science ®Google Scholar
• Singh M, Wang NC, Jain S, et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol. 2015;66(23):2607–2613.
   Web of Science ®Google Scholar
• Kober L, Thune JJ, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–1230.
   PubMed Web of Science ®Google Scholar
• Skowasch D, Ringquist S, Nickenig G, et al. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. PloS ONE. 2018;13(3):e0194496.
   Web of Science ®Google Scholar
• Bigger JT. Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337(22):1569–1575.
   PubMed Web of Science ®Google Scholar
• Zishiri ET, Williams S, et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2013;6(1):117–128.
   Web of Science ®Google Scholar
• Klein HU, Meltendorf U, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33(3):353–367.
   Web of Science ®Google Scholar
• Gronda E, Bourge RC, et al. Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant. 2006;25(9):1043–1056.
   Web of Science ®Google Scholar
• Cantillon DJ, Tarakji KG, Kumbhani DJ, et al. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7(4):466–471.
   Web of Science ®Google Scholar
• Collins KK, Silva JN, Rhee EK, et al. Use of a wearable automated defibrillator in children compared to young adults. Pacing Clin Electrophysiol. 2010;33(9):1119–1124.
   Web of Science ®Google Scholar
• Castro L, Pecha S, et al. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. J Cardiothorac Surg. . 2017;12(1):99.
   Google Scholar
• Healy CA, Carrillo RG. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: a cost-effectiveness evaluation. Heart Rhythm. 2015;12(7):1565–1573.
   Web of Science ®Google Scholar
• Erath JW, Vamos M, Benz AP, et al. Usefulness of the WCD in patients with suspected tachymyopathy. Clin Res Cardiol. 2018;107(1):70–75.
   Web of Science ®Google Scholar
• Lamichhane M, Gardiner JC, Bianco NR, et al. National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy. J Interv Card Electrophysiol. 2017;48(1):11–19.
   Web of Science ®Google Scholar
• Duncker D, König T, Hohmann S, et al. Avoiding untimely implantable cardioverter/defibrillator implantation by intensified heart failure therapy optimization supported by the wearable cardioverter/defibrillator-the PROLONG study. J Am Heart Assoc. 2017;6(1):e004512.
   Web of Science ®Google Scholar
• Kutyifa V, Moss AJ, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation. 2015;132(17):1613–1619.
   Web of Science ®Google Scholar
• Richard Conti C. Automatic external defibrillator, life vest defibrillator, or both? Clin Cardiol. 2010;33(12):722–723.
   Web of Science ®Google Scholar
• Masri A, Altibi AM, et al. Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. JACC Clin Electrophysiol. 2019;5(2):152–161.
   Google Scholar
• Lenarczyk R, Potpara TS, Haugaa KH, et al. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace. 2016;18(1):146–150.
   PubMed Web of Science ®Google Scholar
• Wassnig NK, Gunther M, et al. Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation. 2016;134:635–643.
   PubMed Web of Science ®Google Scholar
• Lifevest.zoll.com. n.d. Imagery | ZOLL LifeVest. [cited 2019 Aug]. [online] available at: https://lifevest.zoll.com/news/imagery.
   Google Scholar